- Home
- BNED vs AVIR Comparison
BNED vs AVIR Comparison
Compare BNED & AVIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BNED | AVIR |
|---|---|---|
| Founded | 1965 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 467.3M | 413.1M |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BNED | AVIR |
|---|---|---|
| Price | $13.58 | $4.04 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $17.25 | $9.42 |
| AVG Volume (30 Days) | 199.8K | ★ 276.1K |
| Earning Date | 09-08-2026 | 11-11-2026 |
| Dividend Yield | ★ 2.29% | N/A |
| EPS Growth | ★ 119.60 | 3.00 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $1,714,770,000.00 | $351,367,000.00 |
| Revenue This Year | $3.88 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 6.50 | N/A |
| 52 Week Low | $5.90 | $2.87 |
| 52 Week High | $14.75 | $6.45 |
Technical Indicators
Market Signals| Indicator | BNED | AVIR |
|---|---|---|
| Relative Strength Index (RSI) | 67.02 | 25.19 |
| Support Level | $11.55 | $3.34 |
| Resistance Level | $14.75 | $4.46 |
| Average True Range (ATR) | 0.43 | 0.24 |
| MACD | 0.18 | -0.09 |
| Stochastic Oscillator | 83.33 | 8.46 |
Price Performance
Historical ComparisonAbout BNED Barnes & Noble Education Inc
Barnes & Noble Education Inc is contract operators of physical and virtual bookstores for college and university campuses and K-12 institutions across the United States. The company is also one of the textbook wholesalers and inventory management hardware and software providers The company operates physical and virtual bookstores that delivers essential educational content and general merchandise within a dynamic omnichannel retail environment. The Company currently operates as a single operating and reporting segment. The company's solutions are Academic Solutions, College Retail Solutions, College Insights, Wholesale & Store Technology Services.
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.